eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Original paper

Available questionnaires do not cover important aspects of quality of life of patients with cutaneous T-cell lymphoma: evaluation of the quality of life of Polish patients with cutaneous T-cell lymphoma

Agnieszka Giza
1
,
Małgorzata Sokołowska-Wojdyło
2
,
Hanna Ciepłuch
3
,
Berenika Olszewska
2
,
Roman J. Nowicki
2
,
Karol Kołkowski
2

  1. Department of Haematology, Jagiellonian University Medical College, Krakow, Poland
  2. Department of Dermatology, Venerology and Allergology, Medical University of Gdansk, Poland
  3. Copernicus. Regional Oncology Centre, Gdansk, Poland
Adv Dermatol Allergol
DOI: https://doi.org/10.5114/ada.2024.145289
Online publish date: 2024/11/24
Article files
- Available.pdf  [0.17 MB]
- Supplement Patients Doctors.pdf  [0.46 MB]
- QoL_CTCL_patient_Supplementary2.pdf  [0.69 MB]
- QoL_CTCL_physician_Supplementary3.pdf  [0.61 MB]
- STROBE-checklist-QoL-CTCL.pdf  [0.10 MB]
Get citation
 
 
1. Ottevanger R, van Beugen S, Evers AWM, et al. Quality of life in patients with mycosis fungoides and Sézary Syndrome: a systematic review of the literature. J Eur Acad Dermatol Venereol 2021; 35: 2377-87.
2. Beatty P, Molloy K, Thornton S. O-142 – insights from the 2020 lymphoma coalition global patient survey on lymphomas and CLL: the burden of fatigue. Eur J Cancer 2023; 190: 113030.
3. Rosenthal JM, Kim EJ. Health-related quality of life in cutaneous T-cell lymphoma: examining all sides of the issue. Br J Dermatol 2020; 182: 20-1.
4. Molloy K, Jonak C, Woei-A-Jin FJSH, et al. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol 2020; 182: 770-9.
5. Bhat TS, Herbosa CM, Rosenberg AR, et al. Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma. Br J Dermatol 2021; 184: 310-8.
6. von Elm E, Altman DG, Egger M, et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ 2007; 85: 867-72.
7. Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019; 133: 1703-14.
8. Scarisbrick JJ, Bagot M, Ortiz-Romero PL. The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T-cell lymphoma. Br J Haematol 2021; 192: 683-96.
9. Rosenthal JM, Kim EJ. Health-related quality of life in cutaneous T-cell lymphoma: examining all sides of the issue. Br J Dermatol 2020; 182: 20-1.
10. Martinez XU, Chowdhury A, Stiller T, et al. The impact of gender, age, race/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas. Support Care Cancer 2021; 29: 6669-79.
11. Shinohara MM, Mahurin HM, Tarabadkar E, et al. Health-related quality of life in cutaneous T-cell lymphoma: a cross-sectional survey study. Skin Health Dis 2021; 1: e45.
12. Wright A, Wijeratne A, Hung T, et al. Prevalence and severity of pruritus and quality of life in patients with cutaneous T-cell lymphoma. J Pain Symptom Manage 2013; 45: 114-9.
13. Demierre MF, Gan S, Jones J, et al. Significant impact of cutaneous T-cell lymphoma on patients’ quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey. Cancer 2006; 107: 2504-11.
14. Ottevanger R, van Beugen S, Evers AWM, et al. Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator. JAAD Int 2022; 9: 57-64.
15. Solak B, Kara RÖ. Systemic inflammation and its relationship with pruritus in early-stage mycosis fungoides. J Cell Mol Med 2024; 28: e18125.
16. Prinsen CA, Lindeboom R, de Korte J. Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. J Invest Dermatol 2011; 131: 1945-7.
17. Illidge T, Chan C, Counsell N, et al. Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma. Br J Cancer 2013; 109: 2566-73.
18. Shalabi D, Kartan S, O’Donnell M, et al. Skindex-29 scores indicate poor quality of life in early stage mycosis fungoides. J Dermatol Sci 2020; 98: 98-101.
19. Semenov YR, Rosenberg AR, Herbosa C, et al. Health-related quality of life and economic implications of cutaneous T-cell lymphoma. Br J Dermatol 2020; 182: 190-6.
20. Nguyen M, LeWitt T, Pang Y, et al. Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study. Arch Dermatol Res 2023; 315: 275-8.
21. Porkert S, Lehner-Baumgartner E, Valencak J, et al. Patients’ illness perception as a tool to improve individual disease management in primary cutaneous lymphomas. Acta Derm Venereol 2018; 98: 240-5.
22. Ottevanger R, Feenstra JS, van Vliet LM, et al. Unveiling the hidden struggles: exploring the profound impact of advanced stage cutaneous T-cell lymphoma on quality of life. Skin Health Dis 2023; 3: e300.
23. Abraham J, Wei G, Desai SR, et al. Perspectives on and quality of life in skin of color patients with mycosis fungoides/Sézary syndrome: a qualitative analysis. Cureus 2023; 15: e34054.
24. Sampogna F, Frontani M, Baliva G, et al. Quality of life and psychological distress in patients with cutaneous lymphoma. Br J Dermatol 2009; 160: 815-22.
25. Chalaka CW, Mahurin HM, Tarabadkar E, et al. Gender disparities in health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma. Int J Womens Dermatol 2023; 9: e085.
26. Gabes M. Are existing quality-of-life instruments in cutaneous T-cell lymphoma of sufficient quality? Br J Dermatol 2021; 184: 195.
27. Xerfan EMS, Andersen ML, Tomimori J, et al. Cutaneous T-cell lymphomas and sleep quality: a bidirectional relationship? Int J Dermatol 2020; 59: e150-1.
28. McCaffrey S, Black RA, Nagao M. Measurement of quality of life in patients with mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma: development of an electronic instrument. J Med Internet Res 2019; 21: e11302.
29. Herbosa CM, Semenov YR, Rosenberg AR, et al. Clinical severity measures and quality-of-life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology-specific instruments. J Eur Acad Dermatol Venereol 2020; 34: 995-1003.
30. Demierre MF, Olsen EA, Williams CA, et al. An in-depth assessment of the impact of pruritus on health-related quality of life of patients with mycosis fungoides/Sézary syndrome. J Support Oncol 2011; 9: e13-9.
31. Gisondi P, Puig L, Richard MA, et al. Quality of life and stigmatization in people with skin diseases in Europe: a large survey from the ‘burden of skin diseases’ EADV project. J Eur Acad Dermatol Venereol 2023; 37 Suppl 7: 6-14.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.